Valeo Financial Advisors, LLC Mereo Biopharma Group PLC Transaction History

Valeo Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 07, 2022	SELL	$1.51 - $2.59 $33,984 - $58,290	-22,506 Closed	0 $0
Q3 2021 Nov 02, 2021	SELL	$2.2 - $3.17 $22,000 - $31,700	-10,000 Reduced 30.76%	22,506 $54,000
Q2 2021 Jul 22, 2021	BUY	$2.94 - $4.08 $73,500 - $102,000	25,000 Added 333.07%	32,506 $103,000
Q1 2021 Apr 12, 2021	BUY	$2.6 - $4.43 $19,500 - $33,225	7,500 Added 125000.0%	7,506 $25,000
Q3 2019 Oct 15, 2019	BUY	$2.22 - $4.14 $13 - $24	6 New	6 $0

107M

209K

479K

Ticker MREO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,986,000
Market Cap $441M
Description
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.